XML 33 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Redeemable Common Stock, Stock Options, Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Redeemable Common Stock
Notes Receivable for Redeemable Common Stock Issued
Redeemable stock options
Convertible Preferred Stock [Member]
Common Stock
Additional Paid-in Capital
Notes Receivable for Common Stock Issued
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Temporary Equity, Beginning Balance, Amount at Dec. 31, 2019   $ 56,422 $ 855 $ 59,631 $ 327,581          
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2019   3,563,884     14,374,455          
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2019 $ (419,809)         $ 46 $ (419,855)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2019           1        
Exercise of stock options   $ 6,075   (5,083)            
Exercise of stock options, shares   249,566                
Exercise of warrants         $ 47          
Exercise of warrants, shares         1,817          
Stock-based compensation expense $ 4,185           4,185      
Conversion of preferred stock to common stock upon initial public offering, shares (14,851,007)                  
Change in notes receivable for common stock issued     52              
Accretion to redemption value of redeemable stock options $ 1,461     (1,463)           1,461
Accretion to redemption value of redeemable stock (43,954) $ 18,283     $ 25,672   (4,185)     (39,769)
Fair Value of unexercised warrants (49)               (49)  
Net income loss 27,575                 27,575
Temporary Equity, Ending Balance, Amount at Dec. 31, 2020 353,300 [1] $ 80,780 803 53,085 $ 353,300          
Temporary Equity, Ending Balance, Shares at Dec. 31, 2020   3,813,450     14,376,272          
Stockholders' Equity, Ending Balance, Amount at Dec. 31, 2020 (430,591)         (3) (430,588)
Stockholders' Equity, Ending Balance, Shares at Dec. 31, 2020           3,813,450        
Stockholders' Equity, Ending Balance, Shares at Dec. 31, 2020 at Dec. 31, 2020           1        
Exercise of stock options 347 $ 6,922   (5,715)     347      
Exercise of stock options, shares   280,545       83,958        
Stock-based compensation expense 7,575           7,575      
Proceeds from notes receivable (136)             (136)    
Exercise of preferred stock warrants, net of shares withheld for exercise price (2,011)       $ 3,912   (2,011)      
Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares         100,261          
Conversion of preferred stock to common stock upon initial public offering $ (357,202)       $ 357,212 $ (15) (357,187)      
Conversion of preferred stock to common stock upon initial public offering, shares (4,093,995)       14,476,533 (14,951,254)        
Surrender of common stock in exchange for cancellation of note receivable, Shares           11,011        
Surrender of common stock in exchange for cancellation of note receivable             (229) 229    
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock $ 86,885 $ (87,702) 817     $ 4 87,698 (817)    
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock, shares   4,093,995       (4,093,995)        
Reclassification of redeemable common stock options to common stock options 47,370     $ (47,370)     47,370      
Change in notes receivable for common stock issued 452   $ (14)         452    
Issuance of common stock in connection with initial public offering, net of issuance costs of $12.4 million 119,582         $ 8 119,574      
Issuance of common stock in connection with initial public offering, net of issuance costs of $12.4 million, shares           8,248,549        
Fair Value of unexercised warrants (7)               (7)  
Foreign currency translation adjustment (10)               (10)  
Net income loss (48,688)                 (48,688)
Temporary Equity, Ending Balance, Shares at Dec. 31, 2021         0          
Stockholders' Equity, Ending Balance, Amount at Dec. 31, 2021 $ 138,242         $ 27 $ 617,511 $ (20) $ (479,276)
Stockholders' Equity, Ending Balance, Shares at Dec. 31, 2021 27,366,746         27,366,746        
[1] The carrying value reflects the gross proceeds received from the sale of the preferred stock less issuance costs and the fair value at issuance of preferred stock warrants classified as a liability, plus accretion of redemption value.